Give to the Department of Medicine

Your generosity makes all the difference

When you give to the Department of Medicine at the University of Alberta, you are investing in the health of Alberta. Supporting research and academic activities for the successful discovery, prevention and treatment of the diseases that may affect you or someone you know.

Research and Education in the Department of Medicine leads to greater knowledge on treatments that best meet the needs of patients and not only affects over one and a half million residents in the metropolitan area of Edmonton, it also affects Alberta’s northern communities we serve providing complex patient care.

Help us ensure timely treatment enhancing quality of life of Alberta. With your generous donation, you make it possible for us to invest in our commitment to training outstanding physicians and researchers which supports health sciences learning.

For more information on giving to the Department of Medicine, please contact Brooke Rose: ber@ualberta.ca

Tax receipts are available for your donation.

Your Generosity's Impact

A groundbreaking U of A followup study on the benefits of cardiac-resynchronization defibrillators shows that the devices continue to be highly effective at saving lives 14 years later. (Photo: Getty Images)

Research by Dr. Soori Sivakumaran and Dr. Shane Kimber show that cardiac-resynchronization defibrillators is still saving lives after 14 years

A long-term followup study by Dr. Soori Sivakumaran (Division of Cardiology) and Dr. Shane Kimber (Division of Cardiology) reveals “tremendous survival advantage” of combining biventricular pacemakers with simpler implantable cardioverter-defibrillators for eligible heart failure patients.

Learn More

The sickest long COVID patients — mostly women — face symptoms that are identical to chronic fatigue syndrome, according to a team of U of A experts who identified deficiencies in two amino acids that may hold the key to new treatments. (Photo: Getty Images)

Research by Dr. Jan Willem Cohen Tervaert show that sickest long COVID patients face symptoms identical to chronic fatigue syndrome

Dr. Cohen Tervaert (Division of Rheumatology) does not believe that long COVID is a separate new disease, but it does require more attention as some infected may never leave their beds.

Learn More

Neurologist Zaeem Siddiqi (centre) with biochemistry professor Richard Fahlman (left) and neurology post-doctoral fellow Faraz Hussain. Their research revealed a blood biomarker for myasthenia gravis and could lead to a simpler, faster test to diagnose the potentially fatal disease and get patients into treatment sooner.

Drs. Zaeem Siddiqi and Faraz Hussain uncover a universal biological marker for myasthenia gravis

Dr. Siddiqi (Division of Neurology), Dr. Hussain (Division of Neurology) and Dr. Fahlman (Department of Biochemistry) have found a simple and universal biomarker for all types of myasthenia gravis regardless of the stage of the disease.

Learn More

Donate Now